About this trial
The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Ability to provide informed consent (knowledge of project languages), >18 years.
Indeterminate or suspicious lung lesion unsuitable for transbronchial biopsy or Status after unsuccessful transbronchial biopsy
Indication for biopsy given by referring specialist (in patients).
Disqualifiers
Preintervention bleeding into the pleural cavity
More than 1 lesion should be biopsied at the same time
Infiltration of the thoracic wall
Pregnancy
Trial design
Parallel
Treatments tested in this trial
Fluid application during ct-guided lung biopsy
Procedure/SurgeryInjection of a small amount of fluid (max. 20 ml sodium chlorid) in the pleural cavity at the biopsy site
Treatment groups
Trial outcomes
Primary outcomes
Number of patients with pneumothorax
Reduction of pneumothorax occurrence in patients with biopsy in dependent lung areas and pleural fluid administration compared to patients with biopsy in dependent lung areas without fluid administration. Immediately after the lung biopsy, the final CT scan of the intervention is used to check whether a pneumothorax is present or not - i.e. whether there is new air in the pleural cavity.
Secondary outcomes
Number of patients with bleeding
Local bleeding in lung parenchyma
Number of patients with chest tube placement
Chest tube placement if pneumothorax is more than 2 cm immediate after biopsy or progressive pneumothorax over time
Number of patients with air embolism
Evidence of air embolism in the postprocedural CT image
Sponsors and contacts
Click on the lead sponsor to view all of their trials.